2Kahaly GJ,Shimony O,Gellman YN,et al.Regulatory Tcells in Graves′orbitopathy:baseline findings and immunomodulation by anti-T lymphocyte globulin[J].J Clin Endocrinol Metab,2011,96(2):422-429.
3Werner SC.Modification of the classification of the eye changes of Graves′disease[J].Am J Ophthalmol,1977,83(5):725-727.
4Bartalena L,Baldeschi L,Dickinson A,et al.Consensus statement of the European Group on Graves′orbitopathy(EUGOGO)on management of GO[J].Eur J Endocrinol,2008,158(3):273-285.
5Bartalena L.The dilemma of how to manage Graves′hyperthyroidism in patients with associated orbitopathy[J].J Clin Endocrinol Metab,2011,96(3):592-599.
6Imbrasiene·D,Jankauskiene·J,Stanislovaitiene·D.Ultrasonic measurement of ocular rectus muscle thickness in patients with Graves′ophthalmopathy[J].Medicina(Kaunas),2010,46(7):472-476.
7Gerding MN,Prummel MF,Wiersinga WM.Assessment of disease activity in Graves′ophthalmopathy by orbital ultrasonography and clinical parameters[J].Clin Endocrinol(Oxf),2000,52(5):641-646.
8Monteiro ML,Moritz RB,Angotti Neto H,et al.Color Doppler imaging of the superior ophthalmic vein in patients with Graves′orbitopathy before and after treatment of congestive disease[J].Clinics(Sao Paulo),2011,66(8):1329-1334.
9Werner SC,Coleman DJ,Franzen LA.Ultrasonographic evidence of a consistent orbital involvement in Graves′disease[J].New Engl J Med,1974,290(26):1447-1450.
10Nugent RA,Belkin RI,Neigel JM,et al.Graves orbitopathy:correlation of CT and clinical findings[J].Radiology,1990,177(3):675-682.
